NCT04940299 2026-03-06Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial CarcinomaM.D. Anderson Cancer CenterPhase 2 Active not recruiting35 enrolled
NCT02812420 2026-03-05Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before SurgeryM.D. Anderson Cancer CenterPhase EARLY_PHASE1 Active not recruiting54 enrolled
NCT06764095 2026-02-12Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI TrialMayo ClinicPhase 4 Recruiting75 enrolled